Shared Care Follow-up After Chemotherapy for Testicular Cancer

TACkLE Study - Tackling Adverse Chemotherapy-associated Late Effects

NCT02276430 ·Status: ACTIVE_NOT_RECRUITING

A Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-resistant Prostate Cancer and Men With Metastatic Prostate Cancer

NCT02066961 ·Status: COMPLETED

Metastasis-directed Therapy for Oligorecurrent Prostate Cancer

NCT05352178 ·Status: RECRUITING ·Phase: PHASE3

Duration of Androgen Blockade Combined With Pelvic Irradiation in Prostate Cancers

NCT00223171 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study Comparing AT-101 in Combination With Docetaxel and Prednisone Versus Docetaxel and Prednisone in Men With Chemotherapy-Naïve Metastatic Hormone Refractory Prostate Cancer (HRPC)

NCT00571675 ·Status: COMPLETED ·Phase: PHASE2

A Phase I/II Study of HE3235 in Patients With Prostate Cancer

NCT00716794 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study to Assess Safety and Tolerability of AZD2171 After Multiple Doses in Patients With Advanced Prostate Cancer

NCT00502164 ·Status: COMPLETED ·Phase: PHASE1

A Pilot Study of Parenteral Testosterone and Oral Etoposide as Therapy for Men With Castration Resistant Prostate Cancer

NCT01084759 ·Status: COMPLETED ·Phase: NA

Orteronel Maintenance Therapy in Patients With Metastatic Castration Resistant Prostate Cancer and Non-progressive Disease After First-line Docetaxel Therapy

NCT01707966 ·Status: COMPLETED ·Phase: PHASE3

Exercise for Advanced Prostate Cancer: a Multicomponent Feasibility Trial

NCT03658486 ·Status: COMPLETED ·Phase: NA

A Study for the Treatment of Hormone Refractory Prostate Cancer (HRPC) in Patients Previously Treated With Chemotherapy

NCT00257478 ·Status: COMPLETED ·Phase: PHASE2

Investigation of Early Hormonotherapy Efficacy of Prostate Cancer

NCT00375687 ·Status: UNKNOWN ·Phase: NA

Cytoreductive Prostatectomy Versus Cytoreductive Prostate Irradiation As a Local Treatment Option for Metastatic Prostate Cancer: a Multicentric Feasibility Trial

NCT03655886 ·Status: COMPLETED ·Phase: PHASE2

Search for Predictive Factors of Resistance to Treatment for Metastatic Castration-resistant Prostate Cancer by Studying the Expression of microRNAs

NCT04662996 ·Status: COMPLETED ·Phase: NA

Estramustine, Docetaxel, and Carboplatin for Patients With Hormone Refractory Prostate Cancer Progressing After Mitoxantrone-Based Chemotherapy.

NCT00183924 ·Status: COMPLETED ·Phase: PHASE2

A COMbined progRamme of Exercise and Dietary ADvice in mEn With Castrate Resistant Prostate Cancer

NCT03017417 ·Status: COMPLETED ·Phase: NA

Towards Optimal Prescription of Chemotherapy in Prostate Cancer

NCT02512185 ·Status: COMPLETED

Capecitabine in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

NCT00006023 ·Status: COMPLETED ·Phase: PHASE2

Study of Treatment Choice in Patients With Localized Prostate Cancer

NCT01177865 ·Status: UNKNOWN ·Phase: NA

Hormone Therapy With or Without Definitive Radiotherapy in Metastatic Prostate Cancer

NCT02913859 ·Status: UNKNOWN ·Phase: PHASE2

Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors

NCT05611307 ·Status: TERMINATED

The Impact of the COVID-19 Pandemic on Testicular Cancer

NCT05083143 ·Status: COMPLETED

Androgen Ablation With or Without Docetaxel in Treating Patients With Advanced Prostate Cancer

NCT00796458 ·Status: UNKNOWN ·Phase: PHASE3

Evaluation of the Effect of Psycho-oncological Intervention on Well-being of Patients With Advanced Prostate Cancer on LHRH Analogs and Their Partners. A Randomized Controlled Pilot Study.

NCT01562522 ·Status: TERMINATED ·Phase: PHASE2

An Open Label Exploratory Study in Newly Diagnosed Prostate Cancer Patients

NCT00235794 ·Status: COMPLETED ·Phase: NA